“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: P4.19 Extracorporeal photopheresis for treatment in hematological diseases : a single centre experience

€2.42

SKU: product-article-19617 Category: General

Description
Reviews (0)

Description

P4.19 Extracorporeal photopheresis for treatment in hematological diseases : a single centre experience

Reviews

There are no reviews yet.

Be the first to review “Article: P4.19 Extracorporeal photopheresis for treatment in hematological diseases : a single centre experience”

Top

Article: P4.19 Extracorporeal photopheresis for treatment in hematological diseases : a single centre experience

Description

Reviews

Related products

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: Highlights in respiratory oncology

Article: Highlights in digestive oncology

Article: Highlights in gynaecological cancers